MEDGENE'S RHDV2 VACCINE GRANTED CRITICAL LICENSE BY USDA'S CENTER FOR VETERINARY BIOLOGICS
BROOKINGS, S.D., Nov. 2, 2023 /PRNewswire/ -- Medgene, an animal health company that produces highly-targeted platform vaccines, has been granted a Conditional Use License by the United States Department of Agriculture's Center for Veterinary Biologics (USDA-CVB) to further manufacture and distribute its vaccine targeted at Rabbit Hemorrhagic Disease (RHDV2).
- BROOKINGS, S.D., Nov. 2, 2023 /PRNewswire/ -- Medgene, an animal health company that produces highly-targeted platform vaccines, has been granted a Conditional Use License by the United States Department of Agriculture's Center for Veterinary Biologics (USDA-CVB) to further manufacture and distribute its vaccine targeted at Rabbit Hemorrhagic Disease (RHDV2).
- Once contracted, RHDV2 is usually fatal and affects wild and domestic rabbit populations.
- Medgene's Conditional Use License is especially important for designated State Veterinarians as they are the authority allowing distribution of the vaccine within their respective states.
- Rabbit owners are encouraged to contact their local veterinarian for more information on RHDV2 and vaccination.